A European observational registry collecting efficacy and safety data in newly diagnosed pediatric Philadelphia-positive (Ph+) Acute Lymphoblastic Leukemia (ALL) patients treated with chemotherapy + imatinib ± hematopoietic stem cell treatment (±HSCT) First published 29/05/2014 Last updated 14/03/2024 EU PAS number:EUPAS6665 Study Finalised